Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathogenesis of adynamic bone disease].

H Ogata1, T Ito, E Kinugasa

  • 1Department of Internal Medicine, Showa University Northern Yokohama Hospital.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Adynamic bone disease (ABD), a common renal osteodystrophy, stems from hypoparathyroidism and low bone turnover. Factors like diabetes, age, uremic toxins, and treatments contribute to ABD development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between ischaemia-modified albumin and intermediate-density lipoprotein in haemodialysis patients with end-stage renal disease.

The Journal of international medical research·2011
Same author

Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial.

Clinical nephrology·2009
Same author

[A case of paroxysmal nocturnal hemoglobinuria combined with focal segmental glomerular sclerosis].

Nihon Jinzo Gakkai shi·2001
Same author

[Dialysis encephalopathy, dialysis dementia].

Ryoikibetsu shokogun shirizu·2000
Same author

[Therapy of chronic kidney failure--from the conservative stage to transplantation. Discussion].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2000
Same author

Plasma exchange for acquired hemophilia: a case report.

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis·1999

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Context:

  • Adynamic bone disease (ABD) is the most prevalent form of renal osteodystrophy (ROD).
  • Pathogenesis involves relative hypoparathyroidism and low bone turnover.
  • Associated factors include diabetes, advanced age, uremic toxins, and ROD treatments like calcium-based phosphate binders and active vitamin D metabolites.

Purpose:

  • To elucidate the key factors contributing to the pathogenesis of adynamic bone disease (ABD) in renal osteodystrophy (ROD).
  • To explore the roles of individual patient factors and common ROD treatments in ABD development.

Summary:

  • Relative hypoparathyroidism and low bone turnover are central to adynamic bone disease (ABD) pathogenesis.
  • Individual factors (diabetes, age, uremic toxins) and ROD treatments (calcium-containing phosphorus binders, active vitamin D) are implicated.
  • Emerging research suggests potential links between ABD and vitamin D receptor (VDR) polymorphism or malnutrition.

Impact:

  • Provides a comprehensive overview of ABD pathogenesis, crucial for understanding and managing renal osteodystrophy.
  • Highlights the multifactorial nature of ABD, emphasizing the interplay between patient-specific conditions and therapeutic interventions.
  • Suggests avenues for future research into genetic predispositions (VDR polymorphism) and nutritional status in ABD.

Related Experiment Videos